Peoples Bank (Kansas)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
2,947
-50
-2% -$18.5K 1.11% 30
2026
Q1
$877K Sell
2,997
-135
-4% -$44.4K 0.88% 37
2025
Q4
$1.1M Sell
3,132
-65
-2% -$22K 1.1% 27
2025
Q3
$1.03M Sell
3,197
-332
-9% -$103K 1.03% 32
2025
Q2
$1.37M Sell
3,529
-160
-4% -$64.4K 0.92% 35
2025
Q1
$1.6M Sell
3,689
-5
-0.1% -$2.01K 1.09% 29
2024
Q4
$1.36M Sell
3,694
-130
-3% -$54.4K 0.94% 32
2024
Q3
$1.99M Hold
3,824
1.33% 22
2024
Q2
$2.07M Sell
3,824
-51
-1% -$27K 1.62% 16
2024
Q1
$2.01M Sell
3,875
-75
-2% -$37.3K 1.57% 18
2023
Q4
$1.86M Sell
3,950
-32
-0.8% -$14.8K 1.49% 19
2023
Q3
$1.73M Buy
+3,982
New +$1.81M 1.48% 19

Other funds holding ELV

Peoples Bank (Kansas)'s ELV Position: Q2 2026 in Review

Peoples Bank (Kansas) reduced its Elevance Health (ELV) stake by 1.7% in Q2 2026, selling an estimated $18.5K and leaving 2,947 shares worth $1.14M. The position accounts for 1.11% of the portfolio, ranked #30.

Peoples Bank (Kansas) first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.07M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Peoples Bank (Kansas) held 2,947 shares of Elevance Health worth $1.14M as of Q2 2026.
  • Peoples Bank (Kansas) sold 50 Elevance Health shares in Q2 2026, an estimated $18.5K.
  • Elevance Health made up 1.11% of Peoples Bank (Kansas)'s portfolio in Q2 2026, its #30 holding.
  • Peoples Bank (Kansas) first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • Peoples Bank (Kansas)'s Elevance Health position peaked at $2.07M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2026, filed 10 Jul 2026.